HuGE Literature Finder
Records 1-30
|
A comprehensive analysis of somatic alterations in Chinese ovarian cancer patients.
Scientific reports 2021 Jan 11 (1): 387. Zhang Yingli, Shi Xiaoliang, Zhang Jiejie, Chen Xi, Zhang Peng, Liu Angen, Zhu T |
|
Whole-exome sequencing of non-BRCA1/BRCA2 mutation carrier cases at high-risk for hereditary breast/ovarian cancer.
Human mutation 2020 Dec . Felicio Paula S, Grasel Rebeca S, Campacci Natalia, de Paula Andre E, Galvão Henrique C R, Torrezan Giovana T, Sabato Cristina S, Fernandes Gabriela C, Souza Cristiano P, Michelli Rodrigo D, Andrade Carlos E, Barros Bruna Durães de Figueiredo, Matsushita Marcus M, Revil Timothée, Ragoussis Jiannis, Couch Fergus J, Hart Steven N, Reis Rui M, Melendez Matias E, Tonin Patricia N, Carraro Dirce M, Palmero Edenir |
|
Association of Molecular Genetic Markers of TP53, MDM2, and CDKN1A Genes with Progression-Free Survival of Patients with Ovarian Cancer after Platinum-Based Chemotherapy.
Bulletin of experimental biology and medicine 2020 Aug 169 (4): 486-490. Zavarykina T M, Tyulyandina A S, Khokhlova S V, Khabas G N, Asaturova A V, Nosova Yu A, Brenner P K, Kapralova M A, Atkarskaya M V, Khodyrev D S, Burdennyi A M, Loginov V I, Stenina M B, Sukhikh G |
|
Exon splicing analysis of intronic variants in multi-gene cancer panel testing for hereditary breast/ovarian cancer.
Cancer science 2020 Aug . Ryu Jin-Sun, Lee Hye-Young, Cho Eun Hae, Yoon Kyong-Ah, Kim Min-Kyeong, Joo Jungnam, Lee Eun-Sook, Kang Han-Sung, Lee Seeyoun, Lee Dong Ock, Lim Myong Cheol, Kong Sun-You |
|
Germline variants in DNA repair genes associated with hereditary breast and ovarian cancer syndrome: analysis of a 21 gene panel in the Brazilian population.
BMC medical genomics 2020 Feb 13 (1): 21. da Costa E Silva Carvalho Simone, Cury Nathalia Moreno, Brotto Danielle Barbosa, de Araujo Luiza Ferreira, Rosa Reginaldo Cruz Alves, Texeira Lorena Alves, Plaça Jessica Rodrigues, Marques Adriana Aparecida, Peronni Kamila Chagas, Ruy Patricia de Cássia, Molfetta Greice Andreotti, Moriguti Julio Cesar, Carraro Dirce Maria, Palmero Edenir Inêz, Ashton-Prolla Patricia, de Faria Ferraz Victor Evangelista, Silva Wilson Arau |
|
Molecular profiling identifies synchronous endometrial and ovarian cancers as metastatic endometrial cancer with favorable clinical outcome.
International journal of cancer 2020 Feb . Reijnen C, Küsters-Vandevelde H V N, Ligtenberg M J L, Bulten J, Oosterwegel M, Snijders M P L M, Sweegers S, de Hullu J A, Vos M C, van der Wurff A A M, van Altena A M, Eijkelenboom A, Pijnenborg J M |
|
The contribution of germline predisposition gene mutations to clinical subtypes of invasive breast cancer from a clinical genetic testing cohort.
Journal of the National Cancer Institute 2020 Feb . Hu Chunling, Polley Eric C, Yadav Siddhartha, Lilyquist Jenna, Shimelis Hermela, Na Jie, Hart Steven N, Goldgar David E, Shah Swati, Pesaran Tina, Dolinsky Jill S, LaDuca Holly, Couch Fergus |
|
Therapeutic options for mucinous ovarian carcinoma.
Gynecologic oncology 2020 Jan . Gorringe Kylie L, Cheasley Dane, Wakefield Matthew J, Ryland Georgina L, Allan Prue E, Alsop Kathryn, Amarasinghe Kaushalya C, Ananda Sumitra, Bowtell David D L, Christie Michael, Chiew Yoke-Eng, Churchman Michael, DeFazio Anna, Fereday Sian, Gilks C Blake, Gourley Charlie, Hadley Alison M, Hendley Joy, Hunter Sally M, Kaufmann Scott H, Kennedy Catherine J, Köbel Martin, Le Page Cecile, Li Jason, Lupat Richard, McNally Orla M, McAlpine Jessica N, Pyman Jan, Rowley Simone M, Salazar Carolina, Saunders Hugo, Semple Timothy, Stephens Andrew N, Thio Niko, Torres Michelle C, Traficante Nadia, Zethoven Magnus, Antill Yoland C, Campbell Ian G, Scott Clare |
|
Identification of germline pathogenic variants in DNA damage repair genes by a next-generation sequencing multigene panel in BRCAX patients.
Clinical biochemistry 2019 Nov . Rodríguez-Balada Marta, Roig Bàrbara, Melé Mireia, Albacar Cinta, Serrano Sara, Salvat Mònica, Querol Montserrat, Borràs Joan, Martorell Lourdes, Gumà Jos |
|
Identification of novel mutations of ovarian cancer-related genes from RNA-sequencing data for Japanese epithelial ovarian cancer patients.
Endocrine journal 2019 Nov . Nagasawa Saya, Ikeda Kazuhiro, Horie-Inoue Kuniko, Sato Sho, Takeda Satoru, Hasegawa Kosei, Inoue Satos |
|
Germline and somatic mutations of multi-gene panel in Chinese patients with epithelial ovarian cancer: a prospective cohort study.
Journal of ovarian research 2019 Aug 12 (1): 80. Li Wenhui, Shao Di, Li Lei, Wu Ming, Ma Shuiqing, Tan Xianjie, Zhong Sen, Guo Fengming, Wang Zhe, Ye Mingz |
|
Liquid biopsy-based comprehensive gene mutation profiling for gynecological cancer using CAncer Personalized Profiling by deep Sequencing.
Scientific reports 2019 Jul 9 (1): 10426. Iwahashi Naoyuki, Sakai Kazuko, Noguchi Tomoko, Yahata Tamaki, Matsukawa Hitomi, Toujima Saori, Nishio Kazuto, Ino Kazuhi |
|
Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancer.
Cancer 2019 Jun . Weitzel Jeffrey N, Neuhausen Susan L, Adamson Aaron, Tao Shu, Ricker Charité, Maoz Asaf, Rosenblatt Margalit, Nehoray Bita, Sand Sharon, Steele Linda, Unzeitig Gary, Feldman Nancy, Blanco Amie M, Hu Donglei, Huntsman Scott, Castillo Danielle, Haiman Christopher, Slavin Thomas, Ziv El |
|
Loss of 1p36.33 Frequent in Low-Grade Serous Ovarian Cancer.
Neoplasia (New York, N.Y.) 2019 May 21 (6): 582-590. Van Nieuwenhuysen Els, Busschaert Pieter, Laenen Annouschka, Moerman Philippe, Han Sileny N, Neven Patrick, Lambrechts Diether, Vergote Igna |
|
Survival Following Chemotherapy in Ovarian Clear Cell Carcinoma is Not Associated with Pathological Misclassification of Tumor Histotype.
Clinical cancer research : an official journal of the American Association for Cancer Research 2019 Apr . Takenaka Masataka, Köbel Martin, Garsed Dale W, Fereday Sian, Pandey Ahwan, Etemadmoghadam Dariush, Hendley Joy, Kawabata Ayako, Noguchi Daito, Yanaihara Nozomu, Takahashi Hiroyuki, Kiyokawa Takako, Ikegami Masahiro, Takano Hirokuni, Isonishi Seiji, Ochiai Kazuhiko, Traficante Nadia, Gadipally Sreeja R, Semple Timothy, Vassiliadis Dane, Amarasinghe Kaushalya Christmalee, Li Jason, Mir Arnau Gisela, Okamoto Aikou, Friedlander Michael, Bowtell David D |
|
Impact of somatic molecular profiling on clinical trial outcomes in rare epithelial gynecologic cancer patients.
Gynecologic oncology 2019 Feb . Rodriguez-Freixinos V, Lheureux S, Mandilaras V, Clarke B, Dhani N C, Mackay H, Butler M O, Wang L, Siu L L, Kamel-Reid S, Stockley T, Bedard P L, Oza A |
|
Diagnosis of Li-Fraumeni Syndrome: Differentiating TP53 germline mutations from clonal hematopoiesis: Results of the observational AGO-TR1 trial.
Human mutation 2018 Sep . Weber-Lassalle Konstantin, Harter Philipp, Hauke Jan, Ernst Corinna, Kommoss Stefan, Marmé Frederik, Weber-Lassalle Nana, Prieske Katharina, Dietrich Dimo, Borde Julika, Pohl-Rescigno Esther, Reuss Alexander, Ataseven Beyhan, Engel Christoph, Stingl Julia C, Schmutzler Rita K, Hahnen Er |
|
Association of Breast and Ovarian Cancers With Predisposition Genes Identified by Large-Scale Sequencing.
JAMA oncology 2018 Aug . Lu Hsiao-Mei, Li Shuwei, Black Mary Helen, Lee Shela, Hoiness Robert, Wu Sitao, Mu Wenbo, Huether Robert, Chen Jefferey, Sridhar Srijani, Tian Yuan, McFarland Rachel, Dolinsky Jill, Tippin Davis Brigette, Mexal Sharon, Dunlop Charles, Elliott Aar |
|
Targeted next generation sequencing identifies functionally deleterious germline mutations in novel genes in early-onset/familial prostate cancer.
PLoS genetics 2018 Apr 14 (4): e1007355. Paulo Paula, Maia Sofia, Pinto Carla, Pinto Pedro, Monteiro Augusta, Peixoto Ana, Teixeira Manuel |
|
Gene panel testing of 5589 BRCA1/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer.
Cancer medicine 2018 Mar . Hauke Jan, Horvath Judit, Groß Eva, Gehrig Andrea, Honisch Ellen, Hackmann Karl, Schmidt Gunnar, Arnold Norbert, Faust Ulrike, Sutter Christian, Hentschel Julia, Wang-Gohrke Shan, Smogavec Mateja, Weber Bernhard H F, Weber-Lassalle Nana, Weber-Lassalle Konstantin, Borde Julika, Ernst Corinna, Altmüller Janine, Volk Alexander E, Thiele Holger, Hübbel Verena, Nürnberg Peter, Keupp Katharina, Versmold Beatrix, Pohl Esther, Kubisch Christian, Grill Sabine, Paul Victoria, Herold Natalie, Lichey Nadine, Rhiem Kerstin, Ditsch Nina, Ruckert Christian, Wappenschmidt Barbara, Auber Bernd, Rump Andreas, Niederacher Dieter, Haaf Thomas, Ramser Juliane, Dworniczak Bernd, Engel Christoph, Meindl Alfons, Schmutzler Rita K, Hahnen Er |
|
Prevalence of germline BRCA mutations among women with carcinoma of the peritoneum or fallopian tube.
Journal of gynecologic oncology 2018 Mar . Choi Min Chul, Bae Jin Sik, Jung Sang Geun, Park Hyun, Joo Won Duk, Song Seung Hun, Lee Chan, Kim Ji Ho, Lee Ki Chan, Lee Sunghoon, Lee Je |
|
Distinct homologous recombination gene expression profiles after neoadjuvant chemotherapy associated with clinical outcome in patients with ovarian cancer.
Gynecologic oncology 2018 03 148 (3): 553-558. Kessous Roy, Octeau David, Klein Kathleen, Tonin Patricia N, Greenwood Celia M T, Pelmus Manuela, Laskov Ido, Kogan Liron, Salvador Shannon, Lau Susie, Yasmeen Amber, Gotlieb Walter |
|
Gene-panel testing of breast and ovarian cancer patients identifies a recurrent RAD51C duplication.
Clinical genetics 2018 03 93 (3): 595-602. Pelttari L M, Shimelis H, Toiminen H, Kvist A, Törngren T, Borg Å, Blomqvist C, Bützow R, Couch F, Aittomäki K, Nevanlinna |
|
High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population.
Hereditary cancer in clinical practice 2018 16 12. Maksimenko J, Irmejs A, Trofimovi?s G, B?rzi?a D, Skuja E, Purkalne G, Miklaševi?s E, Gardovskis |
|
Prevalence of deleterious mutations among patients with breast cancer referred for multigene panel testing in a Romanian population.
Clujul medical (1957) 2018 91 (2): 157-165. Goidescu Iulian Gabriel, Caracostea Gabriela, Eniu Dan Tudor, Stamatian Florin Vasi |
|
No association between TP53 Arg72Pro polymorphism and ovarian cancer risk: evidence from 10113 subjects.
Oncotarget 2017 Dec 8 (68): 112761-112769. Zhang Anqi, Shi Ting-Yan, Zhao Yuan, Xiang Junmiao, Yu Danyang, Liang Zongwen, Xu Chaoyi, Zhang Qiong, Hu Yue, Wang Danhan, He Jing, Duan Pi |
|
Mutational heterogeneity in non-serous ovarian cancers.
Scientific reports 2017 Aug 7 (1): 9728. Teer Jamie K, Yoder Sean, Gjyshi Anxhela, Nicosia Santo V, Zhang Chaomei, Monteiro Alvaro N |
|
Genomic analysis of inherited breast cancer among Palestinian women: Genetic heterogeneity and a founder mutation in TP53.
International journal of cancer 2017 08 141 (4): 750-756. Lolas Hamameh Suhair, Renbaum Paul, Kamal Lara, Dweik Dima, Salahat Mohammad, Jaraysa Tamara, Abu Rayyan Amal, Casadei Silvia, Mandell Jessica B, Gulsuner Suleyman, Lee Ming K, Walsh Tom, King Mary-Claire, Levy-Lahad Ephrat, Kanaan Moe |
|
The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk.
NPJ breast cancer 2017 3 22. Slavin Thomas P, Maxwell Kara N, Lilyquist Jenna, Vijai Joseph, Neuhausen Susan L, Hart Steven N, Ravichandran Vignesh, Thomas Tinu, Maria Ann, Villano Danylo, Schrader Kasmintan A, Moore Raymond, Hu Chunling, Wubbenhorst Bradley, Wenz Brandon M, D'Andrea Kurt, Robson Mark E, Peterlongo Paolo, Bonanni Bernardo, Ford James M, Garber Judy E, Domchek Susan M, Szabo Csilla, Offit Kenneth, Nathanson Katherine L, Weitzel Jeffrey N, Couch Fergus |
|
The frequency of cancer predisposition gene mutations in hereditary breast and ovarian cancer patients in Taiwan: From BRCA1/2 to multi-gene panels.
PloS one 2017 12 (9): e0185615. Sung Pi-Lin, Wen Kuo-Chang, Chen Yi-Jen, Chao Ta-Chung, Tsai Yi-Fang, Tseng Ling-Ming, Qiu Jian-Tai Timothy, Chao Kuan-Chong, Wu Hua-Hsi, Chuang Chi-Mu, Wang Peng-Hui, Huang Chi-Ying |
- Page last reviewed:Oct 1, 2020
- Page last updated:Mar 05, 2021
- Content source: